The invention generally relates to the fields of drug delivery and cell capture. In particular, the invention relates to amphiphilic dendron-coils, micelles thereof and their use for drug delivery vehicles and/or cell capture.

The invention generally relates to the fields of drug delivery and cell capture. In particular, the invention relates to amphiphilic dendron-coils, micelles thereof and their use for drug delivery vehicles and/or cell capture.

Disclosed is an elastomer synthesized by a reacting epoxidized vegetable oil with carboxylic acid to form the elastomer compound. More specifically, disclosed herein is an elastomer compound having a polyester component. The method for making the elastomer comprises mixing a polybasic acid with an alcohol solvent to form a solution, reacting said solution having carboxylic groups with epoxidized vegetable oil, and heating the solution at a range of approximately 50° C. to 80° C., wherein an amorphous polyester elastomer is formed. Also disclosed is an elastomer foam product formed by a reacting epoxidized vegetable oil with carboxylic acid.

A resin layer is formed by filling a polymerizable composition between a substrate and a mold and polymerizing and curing the composition, wherein the polymerizable composition comprises a fluorene compound and a thiol compound comprising 2 to 4 thiol groups, a ratio of the number of sulfur atoms the thiol compound to the number of polymerizable functional groups of the fluorene compound is 0.02 or more and 0.25 or less.

A resin layer is formed by filling a polymerizable composition between a substrate and a mold and polymerizing and curing the composition, wherein the polymerizable composition comprises a fluorene compound and a thiol compound comprising 2 to 4 thiol groups, a ratio of the number of sulfur atoms the thiol compound to the number of polymerizable functional groups of the fluorene compound is 0.02 or more and 0.25 or less.

The present technology relates to a polymer comprising at least one ester repeating unit and one ether repeating unit for use in an electrochemical cell, particularly in electrochemical accumulators such as lithium batteries, sodium batteries, potassium batteries and lithium-ion batteries. More specifically, the use of this polymer as a solid polymer electrolyte (SPE), as a matrix for forming gel electrolytes, or as a binder in an electrode material are also contemplated.

The present technology relates to a polymer comprising at least one ester repeating unit and one ether repeating unit for use in an electrochemical cell, particularly in electrochemical accumulators such as lithium batteries, sodium batteries, potassium batteries and lithium-ion batteries. More specifically, the use of this polymer as a solid polymer electrolyte (SPE), as a matrix for forming gel electrolytes, or as a binder in an electrode material are also contemplated.

A method of preparing thermoplastic polyester elastomer membrane with high binding strength includes the following steps: (a) Adding a reaction solvent to TPEE powder or granules to prepare a solvent mixture, (b) Adding a modifier to the solvent mixture, and mixing uniformly to prepare a first mixture, the modifier including at least one of o-xylylenediamine, m-xylylenediamine, alpha,alpha′-diamino-p-xylene, 2,3,5,6-Tetrachloro-p-xylene-alpha,alpha′-diamine, and 1,3,5,7-Tetraazatricyclodecane. (c) Adding an initiator to the first mixture, and mixing uniformly to prepare a second mixture, (d) Obtaining a finished product by passing the second mixture through an injection laminating process.

A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.

A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.